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Analysis of Noncanonical Calcium-Dependent Protein Kinases in
Toxoplasma gondii by Targeted Gene Deletion Using CRISPR/Cas9
Shaojun Long, Qiuling Wang, L. David Sibley
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
Calcium-dependent protein kinases (CDPKs) are expanded in apicomplexan parasites, especially in Toxoplasma gondiiwhere 14
separate genes encoding these enzymes are found. Although previous studies have shown that several CDPKs play a role in con-
trolling invasion, egress, and cell division in T. gondii, the roles of most of these genes are unexplored. Here we developed a more
efficient method for gene disruption using CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-
associated protein 9) that was modified to completely delete large, multiexonic genes from the genome and to allow serial re-
placement by recycling of the selectable marker using Cre-loxP. Using this system, we generated a total of 24 mutants in type 1
and 2 genetic backgrounds to ascertain the functions of noncanonical CDPKs. Remarkably, although we were able to confirm the
essentiality of CDPK1 and CDPK7, the majority of CDPKs had no discernible phenotype for growth in vitro or infection in the
mouse model. The exception to this was CDPK6, loss of which leads to reduced plaquing, fitness defect in a competition assay,
and reduced tissue cyst formation in chronically infected mice. Our findings highlight the utility of CRISPR/Cas9 for rapid serial
gene deletion and also suggest that additional models are needed to reveal the functions of many genes in T. gondii.
Protein kinases have expanded in eukaryotic genomes to regu-late a variety of essential pathways in signaling and develop-
ment (1, 2). Similar to other eukaryotic cells, apicomplexan par-
asites contain a diverse array of protein kinases that are important
for regulating their complex biology. Apicomplexans contain
many members of the major protein kinase families such as AGC
(containing protein kinases A, G, and C), CMGC (containing
cyclin-dependent, mitogen-activated, and cell division cycle
[CDC]-like kinases), calmodulin kinases (CaMK), and casein ki-
nases (CK) (3, 4). Curiously, apicomplexans lack some common
kinases like protein kinase C and canonical tyrosine kinases and
have reduced number of mitogen-activated protein kinases (3, 4).
They also contain several parasite-specific kinases that are ex-
panded, for example, the FIKK (phenylalanine [F]-isoleucine [I]-
lysine [K]-lysine [K]) kinases in Plasmodium falciparum (5, 6) and
the rhoptry kinases (ROP) implicated in Toxoplasma gondii viru-
lence (7, 8). However, the most novel feature of apicomplexan
kinomes is the expansion of plant-like, calcium-dependent serine/
threonine (S/T) protein kinases (CDPKs) (9).
CDPKs are found in green algae, higher plants, ciliates, and
oomycetes, as well as being in apicomplexan parasites (10). Al-
though they are lacking in animal cells, CDPKs are similar inmany
ways to calcium-calmodulin-dependent kinases (CaMK). How-
ever, instead of the kinase domain being regulated by a separate
calmodulin protein, CDPKs have a fused domain structure be-
tween an N-terminal serine threonine protein kinase and a C-ter-
minal calcium activation domain (CAD) that consists of a calm-
odulin-like module linked to the kinase domain by a junctional
domain (11, 12). A number of CDPKs have been crystallized, and
analysis of their structures has led to an understanding of their
unique activation mechanism (11, 12). In the absence of calcium,
CDPKs are autoinhibited due to the fact that the CAD occludes
the active face of the kinase domain. Peptides from the junctional
domain are capable of inhibiting kinase activity of several CDPKs
in vitro (13, 14), consistent with the finding that the junctional
domain interacts with the kinase domain in the autoinhibited
structure (11, 12). Upon binding to calcium, the CAD domain
completely reorganizes and flips to the backside of the kinase do-
main, opening the nucleotide and substrate binding pockets to
activate the enzyme (11, 12). CDPKs likely arose by fusion of a
calmodulin-like domain containing four EF hands, a structural
feature first described in parvalbumin and that is responsible for
calcium binding, followed by their diversification in plants and
protists (10). The fact that CDPKs are not found in animal cells,
combined with the findings that some of them are essential, has
made them attractive targets for development of inhibitors (15).
CDPKs in apicomplexans have been broadly classified as hav-
ing a canonical domain structure consisting of four EF hands in
the C-terminal CAD with a single N-terminal S/T kinase domain
(9). However, a number of CDPKs contain additional features,
including N-terminal extensions, a variable number of EF hands,
and additional domains such as pleckstrin homology (PK) do-
mains (9). The canonical CDPKs are among the best studied, and
for many of them, their biological roles have been explored in
Plasmodium or T. gondii. For example, T. gondii calcium-depen-
dent protein kinase 1 (TgCDPK1) control ofmicroneme secretion
and regulated disruption of gene expression revealed a strong phe-
notype formotility, invasion, and egress (16). Notably, TgCDPK1
is highly unusual in having a small Gly gatekeeper, rendering it
sensitive to a class of bulky ATP mimics called pyrazolopyrimi-
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dines (16, 17). This fortuitous finding allowed the use of chemical
genetics to validate the function of TgCDPK1 (16, 17), to search
for potential targets (18), and to expand the chemical series to find
more potent inhibitors of parasite growth in vitro (19–21). The
orthologue of TgCDPK1, named CDPK4 in Plasmodium berghei
(the numbering scheme is different for historical reasons), is not
essential during asexual growth in red blood cells but rather is
important for controlling microgamete exflagellation (22), sug-
gesting that CDPKs may not play analogous roles across diverse
members of the phylum.
Perhaps not surprising given the expansion of the CDPK fam-
ily, they can also play partially overlapping roles. For example, loss
of TgCDPK3 also affects parasite egress, and under some condi-
tions microneme secretion andmotility (23). Recent studies indi-
cate that TgCDPK3 acts upstream of TgCDPK1 by controlling
calcium homeostasis, and consistent with this, TgCDPK1 overex-
pression can partially compensate for loss of CDPK3 (24). Al-
though bothTgCDPK1 andTgCDPK3 regulate egress inT. gondii,
this function is provided by CDPK5 in P. falciparum (25). In both
systems, protein kinase G (PKG) is required for egress (23, 25),
and invasion (26, 27), demonstrating that cyclic nucleotide- and
calcium-dependent kinase pathways are intertwined. Although
functional studies have addressed the roles of many canonical
CDPKs, much less is known about those with noncanonical do-
main structures. One exception is CDPK7, which has an unusual
domain structure of several incomplete EF hands in an extended
N-terminal domain that also has a PK domain (9). Regulated sup-
pression of expression of TgCDPK7 affects cell division in T. gon-
dii (28) and early stages in asexual development in P. falciparum
(29), although the precise steps affected by this kinase have not yet
been defined.
Herein we sought to identify the functions of eight noncanoni-
cal CDPKs in T. gondii using the highly efficient CRISPR (clus-
tered regularly interspaced short palindromic repeats)/Cas9
(CRISPR-associated protein 9) system for genetic disruption (30)
or using newly describedmethods for improved gene deletion.We
were easily able to delete all seven noncanonical CDPKs in both
the type 1 and type 2 backgrounds and generated several double
mutants and even triple mutants. The relatively modest pheno-
types of thesemutants suggest roles outside of the conventional in
vitro culture andmousemodels normally used to probe gene func-
tion inT. gondii. Nonetheless, the availability of thesemutants will
foster further studies on their roles in themore complex biology of
T. gondii.
MATERIALS AND METHODS
Parasite and host cell cultivation.Thewild-type RH strain (referred to as
RH88 in reference 31), previously described mutants that are defective in
nonhomologous end joining RHku80 (32) and Pruku80 (33), and ge-
netically modified strains generated here were grown in confluent mono-
layers of human foreskin fibroblast (HFF) cells inD10medium composed
of Dulbecco’s modified Eagle medium (DMEM), 10% fetal bovine serum
(FBS) (HyClone) 2 mM glutamine (Sigma), 10 mM HEPES, pH 7.5
(Sigma), and 20 g/ml gentamicin maintained at 37°C with 5% CO2.
Parasites were allowed to egress naturally, harvested by filtration through
3.0-m polycarbonate membranes, and resuspended in Hanks’ balanced
salt solution (HBSS) containing 10 mM HEPES and 0.1 mM EGTA (re-
ferred to as HHE) as described previously (34). All strains and host cell
lines were determined to be mycoplasma negative using the e-Myco plus
kit (Intron Biotechnology).
Domain prediction for CDPKs.A gene ontology (GO) term search of
ToxoDB using the terms “calcium binding” and “protein kinase activity”
combinedwith a text word search for “calciumdependent protein kinase”
identified 14 protein-coding genes, including previously named CDPKs
(15) and two new proteins annotated as calcium-dependent protein ki-
nase (TgME49_240390) and protein kinase domain-containing protein
(TgME49_237860). Domain predictions were performed using Prosite
(http://prosite.expasy.org/).
Single-gRNA strategy for disruption of CDPK6. A single guide RNA
(gRNA) against the first exon of CDPK6 was generated using Q5 DNA
site-directed mutagenesis (New England BioLabs [NEB]) using specific
primers (see Table S1 in the supplemental material). A LoxP-DHFR-
mCherry (DHFR stands for dihydrofolate reductase) cassette was ampli-
fied using primers that contained short regions of homology to CDPK6
using specific primers (Table S1). The amplicon and the single gRNA
plasmid were combined and transfected into tachyzoites of the RH strain.
Following selection with pyrimethamine, single clones were screened us-
ing primers p1 and p2, and reverse transcription-PCR (RT-PCR) was
performed using primers R1 and R2, R3 and R4 (Table S1).
Double-gRNA CRISPR/Cas9 system. To generate guide RNAs
(gRNAs) to disrupt specific CDPK genes, we modified the previously re-
ported CRISPR Cas9-gRNA plasmid (pSAG1::Cas9-U6::sgUPRT plas-
mid; Addgene plasmid 54467) (30). The single gRNA in this plasmid was
replaced by a short oligonucleotide matching each targeted gene (see Ta-
ble S2 in the supplemental material) using Q5 DNA site-directed mu-
tagenesis (NEB) with a common reverse primer (5=AACTTGACATCCC
CATTTAC3=). CDPK-specific CRISPR-Cas9-gRNA plasmids (Table S2)
were sequenced to confirm the correct sequence of the gRNA. To generate
clean knockouts in T. gondii, a double-gRNA CRISPR/Cas9 system was
designed in which the first gRNA sequence (gRNA1) was placed close to
the start codon with the second gRNA (gRNA2) near the stop codon
(Table S2) of the same gene. To express two gRNAs from a single plasmid,
the gRNA2 expression cassette (U6 promoter-gRNA2-RNA scaffold-
TTTT) was amplified using a common set of primers called 2nd gRNA F
(F stands for forward) (5=CGAATTGGGTACCCAAGTAAGCAGAAGC
ACGCTG3=) and 2nd gRNA R (R stands for reverse) (5=TCGACCTCGA
GAATTAACCCTCACTAAAGG3=) and cloned into the pCAS9-gRNA1
plasmid using restriction sites KpnI and XhoI. A similar strategy was used
to generate a series of pCas9-gRNA1-2 plasmids that were specific for each
CDPK gene (Table S2).
A plasmid named pLoxP-DHFR-mCherry containing a pyrimetham-
ine resistance cassette (i.e., LoxP-DHFR 5=UTR-DHFR-mCherry-LoxP-
DHFR 3=UTR) (Addgene plasmid 70147) was constructed using Gibson
Assembly (New England BioLabs) to combine three PCR amplicons that
were amplified using Q5 high-fidelity DNA polymerase (New England
BioLabs) with primer set 1, 2, and 3 (see Table S3 in the supplemental
material), and a LoxP-DHFR 3= untranslated region (3=UTR) fragment
(set 4) was further cloned to replace the surface antigen 1 (SAG1) 3=UTR.
This plasmid was used as a PCR template to generate amplicons contain-
ing the DHFR resistance cassette flanked by short homology regions (ho-
mology region 1 [HR1] and HR2) to specific CDPK genes that were tar-
geted for disruption by CRISPR/Cas9. HR1 was designed to match the
sequence upstream of the Cas9-gRNA1 cleavage site, and HR2 was de-
signed to match the sequence downstream of the Cas9-gRNA2 cleavage
site, for each specific CDPK gene (Table S4).
Transfection and subcloning. Amplicons containing a LoxP-DHFR-
mCherry cassette flanked by short homology regions (HR1 and HR2)
were purified and combined with their corresponding pCas9-gRNA1-2
plasmids for eachCDPK gene. Freshly harvested parasites (3 106 to 5
106) were electroporated with500 ng of the DHFR amplicon and 3 to 5
g of a corresponding pCas9-gRNA 1-2 plasmid in 200 l of Cytomix
buffer as described previously (35). Following electroporation, parasites
were inoculated onto HFF monolayers in 25-cm2 flasks, grown in D10
medium for 24 h at 5% CO2 and 37°C, followed by addition of 3 M
pyrimethamine. Resistant parasites appeared in 7 to 10 days and were
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subcloned on HFFmonolayers in 96-well plates cultured in D10 medium
at 5% CO2 and 37°C.
Single-clone screening and diagnostic PCR. The genotype of CDPK
knockouts was confirmed by diagnostic PCR using lysates of parasite
clones grown in 96-well plates (see Table S5 in the supplementalmaterial).
For each gene, primer p1 is a forward primer located 300 to 500 bp up-
stream of a CRISPR Cas9-gRNA1 targeting site; primer p2 is a reverse
primer located 100 to 300 bp downstream of a CRISPR Cas9-gRNA2
targeting site; primers p3 and p4 match the endogenous locus of each
gene; primer p5 is a reverse primer matching the DHFR 5=UTR of the
DHFR-mCherry cassette (5=CGGCCGACAGGACGCTACTG3=); primer
p6 is a forward primer from the DHFR 3=UTR of the resistant cassette
(5=CGCTCAAGGCTCGATTGTGG3=). Similar diagnostic PCRs were
performed for each gene, consisting of the following. PCR1 tested the 5=
integration site using primers p1 and p5. PCR2 tested the 3= integration
site using primer p2 and p6.; PCR3was performedwith primers p3 and p4
to confirm the presence/absence of the endogenous gene. and PCR4 was
used to test the insertion of the resistant cassette using primers p1 and p2.
RT-PCR. First-strand cDNA was generated using a SuperScript III
first-strand synthesis kit (Life Technologies). cDNA samples were tested
for quality using primers that amplify a full-length cDNA of CDPK1 (F,
5=ATGGGGCAGCAGGAAAGCACTC3=; R, 5=GTTTCCGCAGAGCTTC
AAGAGC3=). cDNAs from specific CDPK disruptants and knockouts
were tested by RT-PCR using gene-specific primers designed to amplify a
central region of each of the targeted genes (see Table S6 in the supple-
mental material).
Generation of double and triple knockouts. In order to generate se-
quential knockouts, the LoxP-DHFR 5=UTR-DHFR-TS-mCherry-LoxP
(TS stands for thymidylate synthase) cassette in a single- or double-gene
knockoutwas excised by transfection of Cre recombinase (36). To remove
the LoxP-DHFR-mCherry cassette, 50 g of pmin-Cre-GFP (GFP stands
for green fluorescent protein) was electroporated into the knockouts, and
parasites were subcloned on day 2 or 3 on HFF monolayers in 96-well
plates without drug selection. Cloneswere screened using PCR4 described
above using primers p1 andp2 (see Table S5 in the supplementalmaterial)
for each of the targeted genes, in which the excised clones produced a
smaller DNA band. Loss of the DHFR cassette in the excised clones was
confirmed by sensitivity to 3 M pyrimethamine. CDPK knockouts that
were excised of theDHFR cassettewere subsequently used for transfection
to generate sequential gene knockouts.
Plaque assay. Freshly harvested parasites were used to inoculate con-
fluentHFFmonolayers in six-well plates with 200 parasites perwell for the
RHku80 background and grown for 6 days in D10medium at 37°C with
5% CO2, or 250 parasites per well for the Pruku80 background and
grown for 9 days in D10 medium at 37°C with 5% CO2. Two or three
independent experiments were performed with three replicate wells each.
Monolayers were fixed with ethanol for 5 min, stained with 0.5% crystal
violet for 5 min, gently washed with water, and dried at room tempera-
ture. Plaque numbers were counted in each well.
Competition assay. Freshly harvested parasites were seeded on HFF
monolayers in a 25-cm2 flask (T25) at a ratio of 1:1 of the wild-type
RHku80 strain to specific knockout strains and grown inD10mediumat
37°C with 5% CO2. Following replication and natural egress at 2-day
intervals, parasites were subpassaged by 1:10 dilution to new25-cm2 flasks
containing fresh HFF monolayers. Naturally egressed parasites were also
inoculated at2-day intervals onto HFFmonolayers grown on glass cov-
erslips in a 24-well plate and cultured in D10 medium at 37°C with 5%
CO2. After overnight growth, coverslips were fixed with 4% formalin in
phosphate-buffered saline (PBS), permeabilized with 0.05% saponin in
PBS containing 10% goat serum, and used for immunofluorescence (IF)
staining. Parasites were stained with primary antibodies against mCherry
(rat monoclonal antibody [MAb]; Life Technologies) and rabbit anti-
SAG1 and then stainedwith secondary antibodies anti-rat IgGAlexa Fluor
594 (anti-rat IgG labeled with Alexa Fluor 594) and anti-rabbit IgG Alexa
Fluor 488 (Life Technologies). Knockout parasites were recognized by
staining for mCherry (red), while total parasites were detected with SAG1
(green). Samples were repeated in triplicate, and250 parasite vacuoles
were counted on each slide. The ratio of knockout parasites in the popu-
lation was calculated at each time point and graphed in Prism. Experi-
ments were repeated three independent times.
Replication assay. Freshly harvested parasites were seeded on HFF
monolayers grown on glass coverslips in 24-well plates and cultured in
D10 medium at 37°C with 5% CO2 for 24 h. Monolayers were fixed with
4% formalin in PBS, permeabilizedwith 0.05% saponin in PBS containing
10% goat serum, and used for IF staining. Monolayers were stained with
primary antibodies against mouse anti-IMC1 MAb (1:5,000) or rabbit
anti-SAG1 (1:10 000) and followed up with secondary antibodies anti-
mouse IgG Alexa Fluor 488 or anti-rabbit IgG Alexa Fluor 488. The num-
ber of parasites per vacuole was determined by microscopic examination
of250 parasite-containing vacuoles on each of three separate coverslips,
and the percentages of vacuoles with different numbers of parasites were
calculated and graphed in Prism. Experiments were repeated three times.
Acute mouse infection with type 1 strain parasites. Animal studies
were conducted at the Washington University School of Medicine and
were approved by the Institutional Animal Care and Use Committee in
accordance with the Guide for Care and Use of Laboratory Animals (37).
Freshly harvested tachyzoites of the wild-type RHku80 strain ormutants
with this background were tested for acute virulence in the mouse model,
as described previously (38). For experiments using the highly virulent
type 1 strain background, we used outbred CD1 mice, as they normally
succumb to wild-type infection, but provide a sensitive readout for atten-
uation of virulence. Eight- to ten-week-old female CD1 mice (Jackson
Laboratories) were injected intraperitoneally (i.p.) with 100 parasites in a
volume of 200 l of HHE (100 parasites per mouse). Strains were tested
independently in groups of five mice, and survival was monitored daily.
Chronic mouse infections with type 2 strain parasites. Parasites of
the Pruku80 type 2 strain and parasites with gene knockouts in this
background were tested for the ability to induce chronic infection in the
mouse. In the case of type 2 strains, which show intermediate virulence,
the use ofmore-susceptible inbredmice allows for higher cyst counts, thus
potentially revealing differences in chronic infection that might be
masked in outbred animals. Freshly harvested tachyzoites grown in cul-
ture were inoculated i.p. in a volume of 200 l of HHE containing 1,000
parasites per animal in 8- to 10-week-old C57BL/6 mice (Jackson Labo-
ratories). Mice were monitored for survival daily, and surviving animals
were tested serologically by enzyme-linked immunosorbent assay
(ELISA) to establish that they were infected, as described previously (34).
Cyst counting was performed as described previously (39). Briefly, at 30
days postinoculation, brains were harvested, and lysed by passing through
16-gauge needles in PBS. The brain homogenate was permeabilized in
0.25% Triton X-100 and blocked with 10% bovine serum albumin (BSA)
in PBS for 10 min. The homogenate was centrifuged at 400  g, resus-
pended in PBS containing 10% BSA and fluorescein isothiocyanate
(FITC)-conjugated Dolichos biflorus lectin (DBL) (1:100 dilution)
(Sigma) for 30 min at room temperature. The stained brain homogenate
was washed twice with PBS containing 10%BSA and resuspended in PBS.
Aliquots of 12.5 l of the resuspension were examined microscopically
using a Zeiss Axioskop microscope, equipped for epifluorescence. The
counts from eight coverslips were averaged and used to obtain the total
number of cysts in a mouse brain based on adjustment for the volume
examined relative to the total brain homogenate.
In vitro differentiation. Differentiation into bradyzoites was tested
using culture in RPMI 1640 medium (pH 8.1) in the absence of CO2 at
37°C as previously described (40). Parasites cultured in D10 medium at
37°C with 5% CO2 for 2 days were processed in parallel as controls for
induction. After 2 days of culture, monolayers were fixed with 4% forma-
lin in PBS buffer and permeabilized with 0.5% Triton X-100 in PBS con-
taining 10% goat serum.Monolayers were stained with antibodies against
dense granule antigen 7 (GRA7) (rabbit MAb, 1:1,000) (41) followed up
with secondary antibodies anti-rabbit Alexa Fluor 594 (1:2,500), and
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FITC-conjugated DBL (1:1,000). Parasite vacuoles stained fully or par-
tially with DBL were scored as bradyzoite positive, in comparison to the
total number of vacuole detected by GRA7 staining. Three independent
experiments were performed with triplicate samples for each, and 250
parasite vacuoles were counted on each slide.
Statistics. Statistical analyses were performed in Prism (GraphPad)
using a nonparametric Kruskal-Wallis test with Dunn’smultiple compar-
isons. Linear regression analysis for the competition assay was performed
in Prism with a comparison to a theoretical slope of 0. A P value of0.05
was considered significant.
RESULTS
Sequence and expression analyses of noncanonical CDPKs inT.
gondii. Previous studies have identified 12 CDPKs in T. gondii,
many of which have orthologues in other apicomplexans (9). We
searched ToxoDB.org using “calcium binding” and “protein ki-
nase activity” as queries for the putative functions and identified
two new genes (TgME49_240390 andTgME49_237860) that were
candidate CDPKs with a kinase domain and EF hands. Phyloge-
netic analysis based on the kinase domains suggested that they are
close to CDPK4 and CDPK7, and they were named CDPK4B
(TgME49_240390) and CDPK7A (TgME49_237860), respec-
tively (see Fig. S1 in the supplemental material), as previously
discussed (15). Analyses of domain structures of all CDPKs in T.
gondii were performed using an online software PROSITE (http:
//prosite.expasy.org/), which suggested that these CDPKs can be
classed into two groups based on their domain structure. Canon-
ical CDPKs have a serine/threonine (S/T) protein kinase domain
immediately followed by three or four EF hands (CDPK1,
CDPK2, CDPK2a, CDPK2b, CDPK3, and CDPK5), while nonca-
nonical CDPKs have different arrangements of the kinase domain
andEFhands andmay also have other domains, such as zinc finger
or pleckstrin homology (PH) domains (Fig. 1A). For example,
CDPK7 and CDPK7a both contain a PH domain, while CDPK7a
also contains a downstream pseudokinase domain. A number of
FIG 1 (A) Domain structures of noncanonical CDPKs in T. gondii. In the diagram of each CDPK, conserved domains are indicated by boxes. Abbreviations and
symbols are defined below the domain structures. CDPKs with asterisks were targeted in this study. The domain predictions were performed using the online software
Prosite (http://prosite.expasy.org/). aa, aminoacids. (B)Geneexpressiondata forCDPKgenes in the type1RHstrainwereobtained fromhttp://ToxoDB.organdplotted
during two complete cell cycles. S, synthesis,M,mitosis, C, cytokinesis, G1, G1 phase of cell cycle; RMA, robustmultiarray average algorithm. (C) Gene expression data
from samples of oocysts, tachyzoites, and bradyzoites in theT. gondii type 2 strain M4 were obtained from htpp://ToxoDB.org and plotted for each life cycle stage.
The different points indicate unsporulated oocysts (UO), sporulated oocysts on day 10 (SO), tachyzoites in vitro on day 2 (Ty), bradyzoites in vitro on day 8 (By
in vitro), and bradyzoites in vivo on day 21 (By in vivo). Colored lines correspond to each CDPK gene in panels B and C.
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the noncanonical CDPKs also contain EF hands that are N termi-
nal to the kinase domain; these noncanonical CDPKs include
CDPK6, CDPK7, CDPK7a, and CDPK9. Finally, all of the nonca-
nonical CDPKs contain one or more incomplete EF hands.
To examine the expression ofCDPK genes during intracellular
development, we analyzed previously collected microarray data
collected from a synchronized time course of intracellular devel-
opment (42). Expression data forCDPK geneswere obtained from
ToxoDB and plotted over the course of two complete cell cycles
(Fig. 1B). Comparison of these profiles indicated that several of
the noncanonical CDPKs (i.e., CDPK4, CDPK4A, CDPK6, and
CDPK9) varied their expression levels during the cell cycle, and
most of these showed a pattern similar to that ofCDPK1 (Fig. 1B).
In contrast, the remaining genes (i.e., CDPK4B, CDPK7, CDPK7A,
and CDPK8) were constitutively expressed and also showed over-
all lower expression levels (Fig. 1B).We also examined the expres-
sion levels of CDPK genes during different developmental life
stages based on previous transcriptomic data (43). Expression
data for CDPK genes were obtained from ToxoDB and plotted
across different life cycle stages of development (Fig. 1C). Several
of the genes, including CDPK4, CDPK4A, CDPK6, and CDPK7A,
were differentially regulated during parasite development, while
the remaining genes (i.e.,CDPK4B,CDPK7,CDPK8, andCDPK9)
were constitutively expressed (Fig. 1C).
Generation of single CDPK knockouts in the type 1
RHku80 strain. We initially used CRISPR/Cas9 and a single
gRNA placed downstream of the ATG to target the eight nonca-
nonical CDPKs in the RH strain (Fig. 1A). Based on PCR screen-
ing of gDNA, disruptants were obtained for all of the noncanoni-
cal CDPKs with the exception of CDPK1 and CDPK7 (data not
shown). However, mRNA from downstream of the targeted sites
was still detected by RT-PCR in the disruptants for each of the
genes. One example of this is illustrated for the single gRNA
CDPK6 disruptant (see Fig. S2 in the supplemental material).
These residual transcripts could be due to alterative splicing, in-
ternal sites for transcription initiation, or read through the
DHFR-mCherry cassette. Rather than decipher among these po-
tential alternatives, we redesigned the CRISPR strategy to delete
the majority of the coding sequences (CDS) for each of the non-
canonical CDPKs.
Because double-strand DNA breaks (DSBs) generated by
CRISPR/Cas9 are efficiently repaired by the homology-directed
DNA repair (HDR) mechanism in the RHku80 background
(44), we took advantage of this information to develop a system to
generate clean knockouts. We developed a system in which two
CRISPR gRNAs (gRNA1 and gRNA2) were expressed from a sin-
gle CRISPR/Cas9 plasmid that generates two DSBs separately lo-
cated at the 5= and 3= regions of the CDS. This plasmid was
cotransfected with a resistance marker containing a LoxP-DHFR
5=UTR-DHFR-mCherry-LoxP-DHFR 3=UTR cassette flanked by
short homology regions (HR1 and HR2, each of 42 bp) that were
designed to repair the DSBs (Fig. 2A). We tested the efficiency of
this system for deletion of cdpk6. A pyrimethamine-resistant
(Pyrr) pool was generated in about 8 days, and diagnostic PCR
indicated the presence of both flanking regions for the correct
insertion of the DHFR cassette into the endogenous locus. In con-
trast, transfections performed with the CRISPR/Cas9 gRNA1-2
plasmid and a resistance cassette without short homology regions
did not produce a Pyrr pool. Although transfections using only the
resistance cassette containing the short homology regions (HR1
and HR2) produced a Pyrr pool after 2 weeks, they remained neg-
ative by diagnostic PCRs designed to detect the knockout (Fig. 2A
anddata not shown). The Pyrr pool generated from transfection of
the double-CRISPR/Cas9 plasmid plus the resistance cassette with
flanking HRs was cloned by limiting dilutions, and single-cell
clones were screened by diagnostic PCRs (Fig. 2A). Consistent
with the high targeting efficiency in ku80 strains, all clones
screened were positive (Fig. 2B). The trial with the cdpk6 gener-
ation clearly suggested that the strategy using double-CRISPR
gRNAs and the resistance cassette flanked by short homology re-
gions was highly efficient in generating gene knockouts.
The double-gRNA strategy was then applied to all noncanoni-
cal CDPKs in this study. With the exception of CDPK7, we were
able to obtain Pyrr pools for each of the targeted CDPKs. The Pyrr
pools and single clones for the noncanonical CDPKs knockouts
were efficiently generated and tested by the diagnostic PCRs as
illustrated in Fig. 2A. Several independent single clones for each
strain were picked up for screening, and the majority were con-
firmed to be knockouts (see Fig. S3A in the supplemental mate-
rial). Total RNAs from two clones of each strain were extracted
and used for the first cDNA strand synthesis and RT-PCR analy-
ses. As expected, mRNAs of the targeted genes in the knockouts
were not detected (Fig. 2C). These studies confirm that it is pos-
sible to delete theCDS for all of the noncanonical CDPKs, with the
exception of CDPK7, which has previously been reported to be
essential (28).
Phenotypic analyses for singleCDPKknockouts in the type 1
RHku80 strain. To test the phenotype during the lytic cycle,
CDPK knockouts were compared for plaque formation on HFF
monolayers, an assay that captures invasion, replication, egress,
and spread. All of the knockouts produced plaques with equal
efficiency except for the cdpk6 strain, which had a mild but sig-
nificant defect (Fig. 3A). The fitness of the knockouts was further
tested by a competition assay in which they were cocultured with
the background strain RHku80. The competition assay was ini-
tiated with equal number of wild-type and knockout parasites and
the parasites were passaged for 18 days, during which time the
proportion of knockouts was determined at 2-day intervals. Un-
der the null hypothesis, it is expected that the knockout and the
wild type would grow the same and the competition index (CI),
defined by the proportion of mutant versus wild-type parasites at
day 18 divided by proportion of at day 1 (the initial ratio was 1:1 of
mutant to wild type) (45), is expected to equal 1. Most of the
knockout strains did not have obvious growth defects, although
cdpk6, cdpk4, and cdpk7a strains showed mild fitness defects
thatwere significant (i.e., the slopewas significantly different from
0 and the CI is lower than 1) (Fig. 3B). However, the growth
defects of cdpk6 and cdpk4 strains were not attributed to dif-
ferences in parasite replication in HFFmonolayers (Fig. 3C), con-
sistent with the fact there was no obvious difference in the size of
plaques formedby the knockouts (data not shown).We also tested
the survival of mice challenged with wild-type and knockout
strains. Mice infected with the wild type or the various CDPK
knockouts all succumbed to challenge and died with very similar
kinetics, indicating there is no overt in vivo defect (Fig. 3D).
Generation and phenotypic testing of CDPK knockouts in
the type 2 Pruku80 strain. Based on transcriptomic and mi-
croarray data found in ToxoDB, it is likely that the noncanonical
CDPKs are expressed at similar levels in tachyzoites and brady-
zoites during development. However, given the absence of pheno-
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types in the tachyzoite stage, we wondered whether these nonca-
nonical CDPKs might have roles in the bradyzoite stage. As the
RH80ku strain used here does not efficiently differentiate to
other life cycle stages, we undertook the generation of knockouts
for all of the nonessential CDPK knockouts in the type 2
Pruku80 strain (33) using a similar double-CRISPR/Cas9 strat-
egy. The same plasmids and PCR amplicons were transfected into
the Pruku80 strain. Knockout clones were isolated and tested by
diagnostic PCR to confirm the loss of the gene and insertion of the
resistance cassette (see Fig. S3B in the supplemental material) and
loss of expression by RT-PCR (Fig. 4A). Plaque assays performed
for the various CDPK knockouts in the Pruku80 strain showed
results similar to those of the knockouts in the RHku80 strain
with only thecdpk6 strain showing amild yet significant defect in
growth (Fig. 4B). When assayed using an in vitro differentiation
protocol based on induction by culture at pH 8.1, all of the knock-
outs efficiently switched to bradyzoites, as revealed by induction
of cyst wall staining detected with Dolichos bifloris lectin staining
(Fig. 4C).
Generation of multiple CDPK knockouts. Previous studies
with other CDPKs have shown that in some cases they can com-
pensate for each other or that theywork in commonpathways (23,
24). Hence, we considered that the lack of phenotypes for nonca-
nonical CDPKs might reflect redundant functions such that sin-
gle-gene knockouts remain normal. Therefore, we set out to gen-
erate multiple gene knockouts both in the RHku80 and
Pruku80 backgrounds. We chose pairwise double knockouts
based on phylogenetic similarity, althoughmany of the CDPKs lie
on long branch lengths and hence are quite dissimilar from each
other (15).
Because the DHFR resistance cassette is flanked by loxP sites,
we excised this marker from the single knockouts by introducing
Cre recombinase, as described previously (36). In the RHku80
background, we excised the DHFR cassette in the cdpk4a::
DHFR-mCherry and cdpk6::DHFR-mCherry mutants by trans-
fection of a plasmid pCre-GFP, obtaining 20% of clones that
lacked the resistance cassette, as confirmed by PCR (data not
shown). The cleaned-upcdpk6mutantwas then transfectedwith
the CRISPR/Cas9 gRNA1-2/CDPK4 plasmid and the DHFR-
mCherry cassette flanking short homology regions from CDPK4
to generate the double deletion cdpk6 cdpk4::DHFR-mCherry
as confirmedby diagnostic PCRs andRT-PCRs (see Fig. S4A in the
supplemental material). The cleaned-up knockout of cdpk4a
was separately transfected with the CRISPR/Cas9 gRNA1-2
plasmids targeting CDPK4, CDPK6, and CDPK4b, together
with the DHFR-mCherry cassette and corresponding gene-
specific short homology regions. The double knockouts of
cdpk4a cdpk4::DHFR-mCherry, cdpk4a cdpk6::DHFR-
FIG 2 Generation of knockout strains for noncanonical CDPKs in T. gondii using a double CRISPR gRNA system. (A) Schematic of the double CRISPR gRNA
system used to delete a noncanonicalCDPK gene. The strategy uses two short homology regions (HRs) flanking a LoxP-DHFR-mCherry cassette. Abbreviations:
EGFP, enhanced green fluorescent protein; S, the scaffold for gRNA; g1, gRNA1; g2, gRNA2;U6p,T. gondiiU6promoter; HR1 andHR2, short homology regions
1 and 2 (42 bp). The red box in the amplicon is mCherry fused with DHFR-TS. The purple boxes are loxP sites. PCR1 and PCR2 detected the correct insertion
sites using the primer pairs p1-p5 and p2-p6, respectively. PCR3 detected the endogenous locus with primers p3 and p4. PCR4 detected the correct insertion of
theDHFR cassette using primers p1 and p2. (B) PCR screening forcdpk6 knockouts demonstrated the efficiency of the process. Single cloneswere screenedwith
the PCRs shown in panel A. M, molecular size markers. (C) RT-PCR screening for CDPK gene knockouts in the RHku80 background. Two clones for each
knockout strain were tested by RT-PCR. TheCDPK1 gene served as a positive control for cDNA template quality. The wild-type parental strain RHku80 (WT)
is shown for comparison.
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mCherry, and cdpk4a cdpk4b::DHFR-mCherry were effi-
ciently generated as confirmed by diagnostic PCRs and RT-
PCRs (Fig. S4A). Furthermore, two of the double knockouts
(cdpk4a cdpk6::DHFR-mCherry and cdpk4a cdpk4b::
DHFR-mCherry) were transfected with Cre to remove the DHFR
selection cassette and then transfected with the CRISPR/Cas9
gRNA1-2/CDPK4 plasmid and the DHFR-mCherry cassette with
short homology regions from CDPK4 to generate triple-gene
knockouts as confirmed by RT-PCR (Fig. S4A). Four double-gene
knockouts in the Pruku80 strain were generated in the same
way, including cdpk4a cdpk4::DHFR-mCherry, cdpk4a
cdpk6::DHFR-mCherry, cdpk4a cdpk4b::DHFR-mCherry,
and cdpk8 cdpk9::DHFR-mCherry, as confirmed by RT-PCR
(Fig. S4B).
Phenotypic analysis of multiple CDPK knockouts. The
growth of four double and two triple knockouts in the RHku80
strain was assayed by plaque formation on HFF monolayers as
described above. All of the knockouts containingcdpk6 hadmild
yet significant reductions in plaque formation, similar to the sin-
gle cdpk6mutant (Fig. 5A). The double- and triple-gene knock-
outs in theRHku80 strainwere also examined for acute virulence
in CD1 mice. All of the mice inoculated with the wild type or
multiple CDPK knockouts succumbed to infection, with ap-
proximately equal time to death (Fig. 5B). The growth of four
double-gene knockouts in the Pruku80 strain was also tested
using plaque formation on HFF monolayers. We obtained sim-
ilar plaque results with only the cdpk6 knockout showing a
mild, yet significant defect (Fig. 5C). Four of the double-gene
knockouts in the Pruku80 strain were used to infect C57BL/6
mice by i.p. injection. Interestingly, we found that the double-
gene knockout cdpk4a cdpk6::DHFR-mCherry formed sig-
nificantly fewer cysts in mouse brains (Fig. 5D). Although the
cyst burden was also lower with the two other double-gene
knockouts cdpk4a cdpk4::DHFR-mCherry and cdpk4a
FIG 3 Phenotypic analyses of CDPK gene knockouts in the RHku80 strain. (A) Plaque formation performed in six-well plates. Data for the mutants were
compared to the wild-type RHku80 strain using a Kruskal-Wallis test with Dunn’s multiple comparisons (P 0.001). The value for the cdpk6 mutant was
significantly different (P 0.001) from the value for the wild-type RHku80 strain as indicated by the bar and two asterisks. The data are from a combination
of three independent experiments with three wells each. Each symbol represents the value for one well. Bars indicate means  standard deviations. (B)
Competition assay for the knockouts based on coculture with the wild-type RHku80 strain. The ratio of parasites was tested every 2 days (x axis). The number
of knockout vacuoles (mCherry positive) divided by the total number of vacuoles (SAG1 staining)  100  percentage of the population (y axis). The
competition index (CI) (to the right of the knockout strain symbols) is defined by the proportion of mutant versus wild-type parasites on day 18 divided by the
proportion present on day 1 (the initial ratio was 1:1 of mutant and wild type) (45). The average values for three independent experiments are shown plotted as
a linear regression. The slope of the line was tested under the null hypothesis that for mutants that showed no growth defect versus the wild type, the plot of the
line should have a slope of zero; for severalmutants, this hypothesis was rejected as shown by the significance levels (**, P 0.0001; *, P 0.001). (C) Replication
assay forcdpk6 andcdpk4 strains compared to the wild-type RHku80 strain. Parasites grown for 24 h were stained with antibodies against IMC1 and SAG1,
followed by fluorescently conjugated secondary antibodies. The proportion of vacuoles with different numbers of parasites was calculated based onmicroscopic
examination (y axis). The data are from three independent experiments, each with three internal replicates. (D) Survival of mice inoculated with the wild-type
RHku80 strain or CDPK knockouts. CD1 mice were inoculated i.p. with 100 parasites. There were five mice in each group.
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cdpk4b::DHFR-mCherry, this difference was not significant
(Fig. 5D).
DISCUSSION
The CDPK family is amplified and diversified in T. gondii, which
contains more members of this group of kinases than either Plas-
modium or Cryptosporidium (9). Although previous studies have
revealed that TgCDPK1 and TgCDPK3 are important in control-
ling egress and invasion and CDPK2 is essential for bradyzoite
development (46) in T. gondii, little is known about the nonca-
nonical CDPKs in T. gondii. Here we disrupted seven noncanoni-
cal CDPK genes in both the type 1 and type 2 strains of T. gondii.
Remarkably, none of these genes was essential for growth and only
cdpk6 mutants had a mild plaquing defect, which resulted in
decreased fitness and lower chronic tissue cyst burden. To inter-
rogate the possibility of redundancy, we generated a rapid system
for generating serial mutants using CRISPR to recycle selection
cassettes. The lack of an overt phenotype formostmutantswas not
simply due to redundancy as pairwise double and triple mutants
also failed to reveal additional phenotypes over that of the single
cdpk6mutant. Thus, while our findings provide a more efficient
process for generating serial gene deletions in T. gondii, they also
highlight the limitations of existing models for studying the roles
of individual genes in the biology of infection.
The initial development of CRISPR/Cas9 technology inT. gon-
dii relied on gene disruptions caused by nicking of the DNA with
a single gRNA and insertion/deletion of a few base pairs or inser-
tion of a selectablemarker to disrupt the gene coding function (30,
44). However, for multiple exonic genes where the gene models
are often in question, this strategymay not lead to loss of function.
For example, in the present study, when we attempted to disrupt
CDPK genes with a single gRNA, the presence of residual mRNAs
confounded the interpretation of these disruptantmutants.When
employed in a wild-type background, the single-gRNA strategy
might also result in nonhomologous insertion of the drug resis-
tance cassette, further complicating the analysis of mutants. As
such, we modified the original CRISPR/Cas9 method to incorpo-
rate two gRNAs that are placed near the 5= and 3= ends of the CDS,
thus removing the entire coding sequence and replacing it with a
selectable marker. This process is extremely efficient and when
combined with loxP sites flanking the selectable marker, it can
easily be used to recycle the marker for subsequent rounds of
selection. This recycling strategy also potentially alleviates the
concern of using mutant forms of DHFR for selection, which im-
part resistance to the clinically important drug pyrimethamine:
after generation of the mutant, the mutant DHFR gene can be
completely removed from the genome. Alternatively, other mark-
ers such as HXGPRT can be used for both positive and negative
selection, and this strategy has the advantage of not employing
pyrimethamine selection. Collectively, we have developed 24 in-
dependent mutants in T. gondii using an improved method for
gene deletion by CRISPR. Among the set of mutants were seven
mutants with individual gene deletions, four doublemutants, and
two triple mutants in the RHku80 background and seven mu-
FIG 4 Generation of CDPK knockouts in the type 2 strain Pruku80 strain. (A) Confirmation of gene knockouts using RT-PCR for specific genes. Two clones
for each knockout strain and thewild-type Pruku80 strain (WT) are shown. TheCDPK1 gene served as a positive control for cDNA template quality. (B) Plaque
formation performed in six-well plates. Data for the mutants were compared to the RHku80 strain using a Kruskal-Wallis test with Dunn’s multiple compar-
isons. The value for the cdpk6 mutant was significantly different (P 0.01) from the value for the wild-type RHku80 strain as indicated by the bar and two
asterisks. The data are from two independent experiments with three replicates each. (C) In vitro differentiation into bradyzoites based on staining with
FITC-conjugated Dolichos biflorus lectin (DBL). Parasites were induced at pH 8.1 for 2 days (Bradyzoite) or cultured under standard D10 medium conditions
(Tachyzoite). Samples were visualized by staining with GRA7 antibodies and fluorescent secondary antibodies in combination with FITC-labeledDBL. Vacuoles
were scored as partially or fully DBL positive. The data are from two independent experiments, each with three internal replicates.
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tants with individual gene deletions and four double mutants in
the Pruku80 background. The use of CRISPR/Cas9 for serial
gene deletions is thus extremely efficient for interrogating the
members ofmultigene families including screening for redundant
functions.
Despite efficiently generating 24 separate mutants, we were
able to discern only a mild phenotype for one of the genes studied
here:cdpk6mutants showed a decrease in the number of PFU in
both the type 1 RHku80 and type 2 Pruku80 backgrounds.
While ourmanuscript was being reviewed, another study describ-
ing disruption of the noncanonical CDPKs using a single-gRNA
strategy was published (47). This study also failed to find a growth
defect in the disruptants; however, they also did not report a defect
for disruption of CDPK6. This difference from our findings may
be due to the limitations described above for the use of single-
gRNA disruptants or other technical differences in how the phe-
notypes were tested. The decrease in plaque number observed
with our cdpk6 mutant was not the result of a replication defect
or of a defect in entry or egress. Rather, it is likely that loss of
CDPK6 results in decreased survival when the parasites are extra-
cellular, as is the case when they are inoculated in the plaque assay.
In the type 1 background, this did not result in a decrease in vir-
ulence as would be expected, since infection with a single viable
organism of type 1 strains causes lethal infection (48). In contrast,
the lack of CDPK6 in the type 2 background results in a significant
decrease in the number of tissue cysts in the brain. This defect is
likely due to a decrease in expansion and dissemination rather
than an intrinsic defect in differentiation, as all mutants showed
FIG 5 Phenotype analyses of multiple gene knockouts of noncanonical CDPKs in the RHku80 and Pruku80 strains. (A) Plaque formation performed in
six-well plates. Data for the mutants were compared to the RHku80 strain using a Kruskal-Wallis test with Dunn’s multiple comparisons. Values that are
significantly different from the value for the RHku80 strain are indicated by bars and asterisks as follows: *, P 0.01; **, P 0.001; ***, P 0.0001. The data
are from three independent experiments with three wells each. (B) Survival of mice inoculated with the wild-type RHku80 strain or double or triple CDPK
knockouts. CD1mice were inoculated i.p. with 100 parasites. There were fivemice in each group. (C) Plaque formation performed in six-well plates. Data for the
mutants were compared to the Pruku80 strain using a Kruskal-Wallis test withDunn’smultiple comparisons. The value that is significantly different (P 0.01)
from the value for the RHku80 strain is indicated by a bar and asterisk. Data are from two independent experiments with three replicates each. (D) Cyst
formation of double knockouts in the Pruku80 strain tested on C57BL/6mice. Eachmouse was i.p. infected with 1,000 parasites (fivemice in each group). Data
from two independent experiments were combined and tested by a Kruskal-Wallis test with Dunn’s multiple comparisons. The value that was significantly
different (P	 0.0005) from the value for the Pruku80 strain is indicated by the bar and three asterisks. Values that were not significantly different (ns) from the
value for the Pruku80 strain are also indicated.
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the same capacity to differentiate into bradyzoites in vitro, indi-
cating that bradyzoite genes are upregulated normally. Finally,
although we did not complement the defect in the cdpk6 mu-
tants by restoring expression of the protein, the fact that we ob-
served this same phenotype for four separately derivedmutants in
the type 1 and type 2 strains supports the idea that the decreased
fitness of this mutant is due to loss of CDPK6.
Previous studies on the roles of CDPKs in the biology of T.
gondiihave focused primarily onTgCDPK1 andTgCDPK3,which
are important in controlling invasion and egress. TgCDPK1 reg-
ulates microneme secretion and is essential for this process as
shown usingmolecular and chemical genetic approaches (16, 17).
In contrast, while TgCDPK3 can be disrupted, it contributes to the
control of microneme secretion and plays an important role in
response to stimulated egress (23, 49, 50). Consistent with this,
TgCDPK3 mutants have reduced virulence in vivo (51). Among
the other CDPKs, only TgCDPK7 has been reported to be essen-
tial, and genetic knockdown studies indicate that it plays a role in
cell division (28). Our attempts to disrupt these genes using
CRISPR/Cas9 confirmed that they are essential for in vitro growth.
Remarkably, based on the current findings, the remaining nonca-
nonical CDPKs appear to be nonessential for growth in vitro or
infection in the mouse model. This raises the intriguing question
ofwhy this gene family is amplified anddiversifiedwhen it appears
to play a nonessential role in the biology. In particular, it is unclear
why the number and placement of EF hands varies so much
among the noncanonical members. For example, TgCDPK4a and
-4b contain only three intact EF hands, while TgCPK4 has three
incomplete EF hands and none that are complete (Fig. 1). In Ara-
bidopsis, there are also some CDPKs containing degenerated EF
hands with unknown functions (52). However, there are no re-
ports on CDPKs in plants containing N-terminal EF hands or a
PH domain. Given the importance of the EF hand domains in
regulating the activity of canonical CDPKs (11, 12), it is unclear
why they have been modified so extensively in other members.
Twopossibilitiesmight account for this pattern. First, it is possible
that CDPKs are gradually accumulating mutations and becoming
degenerate due to the fact that many of them are no longer essen-
tial. This might be inferred from the domain architecture of
TgCDPK7a, which has a duplicated pseudokinase domain down-
streamof themain kinase domain and only a single intact EF hand
located at the N terminus (Fig. 1). However, even if such degen-
erate CDPKs lack regulation, theymight still serve important roles
in substrate binding, scaffolding, etc., as is seen in the case of
ROP5, a pseudokinase that lacks catalytic activity and yet is critical
for virulence in T. gondii (53, 54). An alternative possibility is
that CDPKs play roles in other aspects of biology not tested
here, for example in other hosts or during other life cycle
stages. CDPKs are expressed widely throughout the life cycle,
so it remains possible that they are important during the sexual
phase that occurs in the cat intestine or during oocyst develop-
ment. For example, CDPK4A is slightly elevated in unsporu-
lated oocysts, while CDPK6 and CDPK7A are elevated in spo-
rulated oocysts, which suggests that they may play roles during
sporozoite formation or transmission via oocysts. Unfortu-
nately, we cannot test this possibility in the genetic back-
grounds used here due to loss of the development of the sexual
stages in these lines.
In summary, we have developed an efficient system for serial
gene deletion using CRISPR/Cas9 combined with loxP to effi-
ciently recycle selectable markers. This system allowed us to rap-
idly generate two dozen mutants in the CDPK family in T. gondii.
Although the majority of these lack discernible phenotypes in
standard assays, this approach should be useful in testing the func-
tion of other multigene families in T. gondii. Our findings also
suggest that additional models are needed to ascertain gene func-
tion on T. gondii, as the currently available models may not ade-
quately assess biological function.
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